🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TST001 is a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclo...
Status
Completed
Location
Zhongshan hospital
Start Date
2022-01-14
Trial ID
NCT05190575
Treatments Being Tested
Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05608785
Treatments Being Tested
This is an open label Phase I/IIa, First in Human trial of TST001, a recomb...
Status
Active Not Recruiting
Location
Banner MD Anderson
Start Date
2020-05-28
Trial ID
NCT04396821
Treatments Being Tested
This is an open-label, multi-center, Phase I trial of TST001. Subjects with...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-08-13
Trial ID
NCT04495296
Treatments Being Tested
Gastric/GEJ adenocarcinomas are aggressive tumors with a high probability o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT06093425